Evaluation of Letters Versus Numbers (ELEVEN) Study
Status
Conditions
Treatments
Details and patient eligibility
About
This is a prospective randomised controlled trial to determine the performance of Best Corrected Visual Acuity (BCVA) scores using the ETDRS number chart were compared with ETDRS alphabet chart in healthy eyes of patients who do not recognise the English alphabet.
Full description
BACKGROUND: The measurement of visual acuity is important in the clinical setting to assess visual function and treatment response, while in research to provide objective clinical outcomes. The current gold standard for visual acuity measurement in most research studies, including major clinical trials, is the Early Treatment Diabetic Retinopathy Study (ETDRS) chart designed by Bailey and Lovie. However, this may not be suitable for participants who are illiterate. Alternatives exist, including the ETDRS numbers chart, Landolt C chart and Tumbling E chart. Existing studies show that the Landolt C and Tumbling E charts are alternatives with agreement with ETDRS letters chart in healthy and diseased eyes. However, the charts are limited by their 25% (if four orientations) or 12.5% (if eight orientations) chance of guessing the orientation of the letter.
The ETDRS numbers chart may overcome this limitation, as it uses five unique numbers instead of a single rotating letter. There are few studies evaluating the different types of visual acuity measurement among those unfamiliar with the English alphabet. Though one study shows high repeatability and agreement between the ETDRS letters and numbers charts in healthy and diseased eyes of English literate individuals and shorter testing duration when using the numbers chart, this finding has not been validated in individuals unfamiliar with the English alphabet. This study aims to evaluate how the ETDRS letters and numbers charts compare in individuals unfamiliar with the English alphabet.
METHODS: Eligible subjects were divided into 2 groups according to level of literacy. Literacy was determined by self-reported exposure to the English alphabet and recognition of the 10 Sloan letters (C, D, H, K, N, O, R, S, V, and Z). Subjects included were classified into the 2 groups: group A, with no exposure to the English alphabet and recognition of <6/10 letters, and group B, with exposure to the English alphabet and recognition of ≥6/10 letters.
Testing: Each subject underwent 2 rounds of BCVA measurements using 2 types of ETDRS charts in randomized sequence as follows: LN or NL (L = ETDRS letters chart, N = ETDRS numbers chart) from Precision Vision® (PV). The randomization of the testing sequence was performed by a study coordinator independent of study recruiter, optometrist or investigator. Sequentially numbered, opaque and sealed envelopes were used for allocation concealment and opened by the optometrist prior to testing.
The tests were performed and recorded by a single optometrist in the same testing room with similar lighting conditions. For every round of testing, the right eye was examined first, followed by the left eye. For the right eye, numbers chart (PV No. 2702A) and letters chart (PV No. 2173) were used. For the left eye, the numbers chart (PV No. 2714A) and letters chart (PV No. 2174) were used. Different charts (with the same optotypes but in different order) were used for right and left eyes to minimize the effect of learning between consecutive tests.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Hong Kong residents
- Age 50 years or above
- Attending Southern District Screening program
Exclusion criteria
- BCVA 20/200 or below
- Any clinically relevant ocular disease that might affect visual acuity
Trial design
Primary purpose
Allocation
Interventional model
Masking
59 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal